ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic
Related Posts
Psaras C, Arah OA, Chew KW, Lee SJ, Javanbakht M, Nianogo RA, Seamans MJ. Opioid agonist therapy adherence trajectories among commercially and publicly insured people[...]
Ko MY, Fowler E, Scott A, Uslan DZ. Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous Leishmania Braziliensis in a Recent[...]
Vijayan T. Libraries Burned, a Life Lived. N Engl J Med. 2025 Jul 5. doi: 10.1056/NEJMp2500746. Epub ahead of print. PMID: 40621845.